Company registration number 15966077 (England and Wales)
CZAJKA CARE GROUP LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
CZAJKA CARE GROUP LTD
COMPANY INFORMATION
Directors
Konrad Czajka
(Appointed 19 September 2024)
Dominic Czajka
(Appointed 29 October 2024)
Daniel Czajka
(Appointed 29 October 2024)
Secretary
Janina Czajka
Company number
15966077
Registered office
Victoria House
66 - 70 Bingley Road
Saltaire
Shipley
West Yorkshire
BD18 4DJ
Auditor
Buckle Barton Limited
Techno Centre
Station Road
Horsforth
Leeds
England
LS18 5BJ
CZAJKA CARE GROUP LTD
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Group statement of comprehensive income
9
Group balance sheet
10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 36
CZAJKA CARE GROUP LTD
STRATEGIC REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the period ended 31 December 2024.

Fair review of the business

Czajka Care Group Ltd was formed in October 2024 to acquire the shares of Redhall Ltd.

The Consolidated Results shown in the Accounts are from the date of acquisition until 31st December 2024.

The 152 beds across 3 Nursing and Residential Care Homes are trading profitably. Higher fees and a continued high occupancy i.e. over 90% should sustain the profitability of the Group.

The refurbishment works to upgrade the Environmental Standards and the CQC ratings of ‘Good’ in the 3 Nursing and Residential Care Homes will assist with the ‘Fit for the Future strategic objectives.

 

The eight houses and Apartments at Fairmount Park have now been completed. One property was sold in the year to 31 December 2024 and six have been sold post year end, with the final Apartment currently being marketed for sale or rental.

All Bank debt on the New Build properties was fully repaid in January 2025.

Principal risks and uncertainties

The NMW increase of 6.7% commencing April 2025 and the Employer NIC increase from 13.8% to 15% with thresholds decreased from £9,100 to £5,000 would require a minimum 10% increase in fees. The Local Authorities and the ICB (Integrated Care Board) have agreed to increase fees on average by 7.56% thus costs i.e. expenditure will need careful monitoring in 2025.

International Recruitment has been the main driver in filling posts which have led to reduced Agency use as well as the redeployment of staff from the now demolished Fairmount Nursing Home. Domestic Recruitment remains a challenge as workers are attracted to higher paid and less demanding jobs.

The Labour Government talking about a New Deal for care workers and a National Care Service underpinned by National Care Standards is to be welcomed. However, the Employment Rights Bill introducing Employment rights from Day 1 is onerous.

Over recent years the Care Quality Commission (CQC) have faced increased scrutiny over its Inspection and Ratings processes. People depend on CQC ratings to make informed decisions about care options. All Czajka Homes are rated ‘Good’ and these ratings need to be maintained.

The group profit before taxation may be impacted by the aforementioned considerations in 2025.

Key performance indicators

The company's key financial and other performance indicators during the period were as follows:

 

 

Unit

2024

 

Gross profit

£

545,837

 

Loss before tax

£

166,243

 

Shareholders’ funds

£

7,214,664

 

CZAJKA CARE GROUP LTD
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 2 -
Stakeholder engagement

Czajka Care Group is a family run business established in Saltaire in 1983. We offer quality award-winning care for retired, elderly and disabled people.

 

We own and operate care homes and nursing homes in Bradford. Brookfield Care Home and Staveley Birkleas Nursing Home, which are in Nab Wood near Shipley, and Currergate Nursing Home in Steeton.

 

We also have a stunning mix of luxury purpose-built retirement houses and apartments for people aged 55 and over at Currergate Mews in Steeton and Fairmount Park in Nab Wood, near the World Heritage Site of Saltaire. These are available through a variety of rental, full and shared equity options.

 

Renowned for offering an exceptional standard of service, our experienced, highly-trained, caring team, tailor our care to meet every individual’s needs. Our five nursing and care homes are designed to be a real ‘home from home’ for our residents.

 

Set within beautiful landscaped gardens with easy access to shops and the local community, family and friends are welcome at all times. Our professional managers oversee all aspects of the running of the homes, ensuring that we provide the highest standards of service every single day.

 

We know that choosing the right care home is important, so our doors are always open for people to come and look round – it’s the best way to get a real feel for the place. Come and meet our friendly staff and talk to the people who live here for a thorough insight into why so many people choose to make our homes their home.

 

Our core values that run through all five of our homes are:

 

Compassion

 

Adaptability

 

Respect

 

Excellence

 

Safety

On behalf of the board

9 September 2025
CZAJKA CARE GROUP LTD
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the period ended 31 December 2024.

Principal activities

The principal activity of the company is that of a holding company.

 

The principal activity of the group is the provision of long term care to the elderly and young disabled, comprising the provision of nursing home facility, retirement communities, related property development and private leisure club operators.

Incorporation

The company was incorporated on 19 September 2024 and commenced to trade on 29 October 2024.

Results and dividends

The results for the period are set out on page 9.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

Konrad Czajka
(Appointed 19 September 2024)
Dominic Czajka
(Appointed 29 October 2024)
Daniel Czajka
(Appointed 29 October 2024)
Financial instruments

 

Price risk, credit risk, liquidity risk and cash flow risk

The business' principal financial instruments comprise bank balances, bank overdrafts, trade debtors, trade creditors and loans to the business. The main purpose of these instruments is to finance the business' operations.

 

In respect of bank balances, the liquidity risk is managed by maintaining a balance between the continuity of funding and flexibility through the use of overdrafts at floating rates of interest. All of the business' cash balances are held in such a way that achieves a competitive rate of interest. The business makes use of money market facilities where funds are available.

 

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits. The amounts presented in the balance sheet are net of allowances for doubtful debtors.

 

Trade creditors' liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.

 

Loans comprise loans from the directors and from financial institutions. The interest rate and monthly repayments on the loans from financial institutions are fixed. The business manages the liquidity risk by ensuring that there are sufficient funds to meet the payments.

Disabled persons

The group's policy is to give full and fair consideration to applications for employment made by disabled persons, having regard to their particular aptitudes and abilities.

 

Disabled employees receive appropriate training to promote their career development within the group. Employees who become disabled are retained in their existing posts where possible or retrained for suitable alternative posts.

CZAJKA CARE GROUP LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 4 -
Employee involvement

Regular meetings are held between senior management and employee representatives to discuss matters of concern. Employees are kept well-informed about the progress and position of the group.

Auditor

Buckle Barton Limited were appointed as auditor to the group and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

On behalf of the board
9 September 2025
CZAJKA CARE GROUP LTD
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 5 -

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the company website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

CZAJKA CARE GROUP LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CZAJKA CARE GROUP LTD
- 6 -
Opinion

We have audited the financial statements of Czajka Care Group Ltd (the 'parent company') and its subsidiaries (the 'group') for the period ended 31 December 2024 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

CZAJKA CARE GROUP LTD
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CZAJKA CARE GROUP LTD
- 7 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but it is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonable be expected to influence the economic decisions of the users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

 

- We obtained an understanding of laws and regulations that affect the group, focusing on those that had a direct effect on the financial statements or that had a fundamental effect on its operations. Key laws and regulations that we identified included the UK Companies Act, tax legislation and employment legislation.

 

- We enquired of the directors for evidence or knowledge of non compliance with relevant laws and regulations. Where applicable we also reviewed reports published by external regulators and any correspondence with them.

- We gained an understanding of the controls that the directors have in place to prevent and detect fraud. We enquired of the directors about any instances of fraud that had taken place during the accounting period.

 

- The risk of fraud and non compliance with laws and regulations and fraud was discussed within the audit team and tests were planned and performed to address these risks.

 

- We enquired of the directors about actual and potential litigation and claims.

 

- We reviewed, on a sampling basis certain invoices and transactions together with board minutes.

 

- In addressing the risk of fraud due to management override of internal controls we tested, on a sampling basis, the appropriateness of journal entries and assessed whether the judgements made in making accounting estimates were indicative of a potential bias.

CZAJKA CARE GROUP LTD
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CZAJKA CARE GROUP LTD
- 8 -

Due to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, as with any audit, there remained a higher risk of non detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing fraud or non compliance with laws and regulations and cannot be expected to detect all fraud and non compliance with laws and regulations.

 

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https//www.frc.org.uk/auditorsresponsibilities. This description forms part of our audit report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Mark Dalton (Senior Statutory Auditor)
For and on behalf of Buckle Barton Limited, Statutory Auditor
Chartered Accountants
Techno Centre
Station Road
Horsforth
Leeds
LS18 5BJ
England
9 September 2025
CZAJKA CARE GROUP LTD
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 9 -
Period
ended
31 December
2024
Notes
£
Turnover
3
1,729,065
Cost of sales
(1,183,228)
Gross profit
545,837
Administrative expenses
(299,550)
Other operating income
777
Operating profit
4
247,064
Interest receivable and similar income
7
15,822
Interest payable and similar expenses
8
(81,643)
Amounts written off investments
9
(15,000)
Profit before taxation
166,243
Tax on profit
10
(68,239)
Profit for the financial period
98,004
Profit for the financial period is all attributable to the owners of the parent company.
Total comprehensive income for the period is all attributable to the owners of the parent company.
CZAJKA CARE GROUP LTD
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 10 -
2024
Notes
£
£
Fixed assets
Goodwill
12
1,169,917
Tangible assets
13
9,117,006
Investment property
14
3,887,893
14,174,816
Current assets
Stocks
17
936,174
Debtors
18
1,597,030
Cash at bank and in hand
607,500
3,140,704
Creditors: amounts falling due within one year
19
(7,377,604)
Net current liabilities
(4,236,900)
Total assets less current liabilities
9,937,916
Creditors: amounts falling due after more than one year
20
(2,474,073)
Provisions for liabilities
Deferred tax liability
22
249,179
(249,179)
Net assets
7,214,664
Capital and reserves
Called up share capital
25
2,225
Merger reserve
7,114,435
Profit and loss reserves
98,004
Total equity
7,214,664
The financial statements were approved by the board of directors and authorised for issue on 9 September 2025 and are signed on its behalf by:
09 September 2025
Director
Company registration number 15966077 (England and Wales)
CZAJKA CARE GROUP LTD
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 11 -
2024
Notes
£
£
Fixed assets
Investments
15
15,104,163
Current assets
Cash at bank and in hand
1
Creditors: amounts falling due within one year
19
(5,569,861)
Net current liabilities
(5,569,860)
Total assets less current liabilities
9,534,303
Creditors: amounts falling due after more than one year
20
(2,445,557)
Net assets
7,088,746
Capital and reserves
Called up share capital
25
2,225
Merger reserve
7,114,435
Profit and loss reserves
(27,914)
Total equity
7,088,746

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £27,914.

The financial statements were approved by the board of directors and authorised for issue on 9 September 2025 and are signed on its behalf by:
09 September 2025
Director
Company registration number 15966077 (England and Wales)
CZAJKA CARE GROUP LTD
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 12 -
Share capital
Merger reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 19 September 2024
-
-
-
-
Period ended 31 December 2024:
Profit and total comprehensive income
-
-
98,004
98,004
Issue of share capital
25
2,225
7,114,435
-
7,116,660
Balance at 31 December 2024
2,225
7,114,435
98,004
7,214,664
CZAJKA CARE GROUP LTD
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 13 -
Share capital
Merger reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 19 September 2024
-
-
-
-
Period ended 31 December 2024:
Profit and total comprehensive income
-
-
(27,914)
(27,914)
Issue of share capital
25
2,225
7,114,435
-
7,116,660
Balance at 31 December 2024
2,225
7,114,435
(27,914)
7,088,746
CZAJKA CARE GROUP LTD
GROUP STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 14 -
2024
Notes
£
£
Cash flows from operating activities
Cash generated from operations
33
180,665
Interest paid
(53,729)
Income taxes paid
(20,924)
Net cash inflow from operating activities
106,012
Investing activities
Cash acquired on purchase of business
250,000
Purchase of tangible fixed assets
(112,126)
Purchase of investment property
(265,096)
Proceeds from disposal of investment property
350,452
Interest received
15,822
Net cash generated from investing activities
239,052
Financing activities
Proceeds from issue of shares
1
Repayment of bank loans
(350,321)
Net cash used in financing activities
(350,320)
Net decrease in cash and cash equivalents
(5,256)
Cash and cash equivalents at beginning of period
-
Cash and cash equivalents at end of period
(5,256)
Relating to:
Cash at bank and in hand
607,500
Bank overdrafts included in creditors payable within one year
(612,756)
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 15 -
1
Accounting policies
Company information

Czajka Care Group Ltd (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Victoria House, 66 - 70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ.

 

The group consists of Czajka Care Group Ltd and all of its subsidiaries.

1.1
Reporting period

The current accounting period represents the period between 19 September 2024 (the date of incorporation) and 31 December 2024.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
1.3
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

1.4
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Czajka Care Group Ltd together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

1.5
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.6
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
1.7
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.8
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings
nil or straight line over 50 years
Plant and equipment
10% straight line
Fixtures, fittings and equipment
25% reducing balance
Motor vehicles
25% reducing balance
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.9
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

 

Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets.

1.10
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
1.11
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.12
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.13
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.14
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.15
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.16
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 21 -
1.17
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.18
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.19
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.20
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2024
£
Turnover analysed by class of business
Sales
1,729,065
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
3
Turnover and other revenue
(Continued)
- 22 -
2024
£
Turnover analysed by geographical market
UK
1,729,065
2024
£
Other revenue
Interest income
15,822
Grants received
8
4
Operating profit
2024
£
Operating profit for the period is stated after charging/(crediting):
Government grants
(8)
Depreciation of owned tangible fixed assets
4,214
Profit on disposal of tangible fixed assets
(54,097)
Amortisation of intangible assets
19,829
Operating lease charges
33,678
5
Auditor's remuneration
2024
Fees payable to the company's auditor and associates:
£
For audit services
Audit of the financial statements of the group and company
5,000
Audit of the financial statements of the company's subsidiaries
26,200
31,200
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 23 -
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the period was:

Group
Company
2024
2024
Number
Number
Administration and support
10
-
Directors
2
-
Care home employees
244
-
Total
256
0

Their aggregate remuneration comprised:

Group
Company
2024
2024
£
£
Wages and salaries
967,102
-
0
Social security costs
84,368
-
Pension costs
17,446
-
0
1,068,916
-
0
7
Interest receivable and similar income
2024
£
Interest income
Other interest income
15,822
8
Interest payable and similar expenses
2024
£
Interest on bank overdrafts and loans
43,213
Finance costs for financial instruments measured at fair value through profit or loss
27,914
Other interest
10,516
Total finance costs
81,643
9
Amounts written off investments
2024
£
Other gains and losses
(15,000)
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 24 -
10
Taxation
2024
£
Current tax
UK corporation tax on profits for the current period
68,692
Adjustments in respect of prior periods
209
Total current tax
68,901
Deferred tax
Origination and reversal of timing differences
(662)
Total tax charge
68,239

The actual charge for the period can be reconciled to the expected charge/(credit) for the period based on the profit or loss and the standard rate of tax as follows:

2024
£
Profit before taxation
166,243
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00%
41,561
Tax effect of expenses that are not deductible in determining taxable profit
26,135
Under/(over) provided in prior years
199
Tax at marginal rate
(131)
Chargeable gains/(losses)
1,952
Deferred tax not recognised
(96)
Fixed asset differences
(1,914)
Current year over/(under) provision
533
Taxation charge
68,239
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 25 -
11
Impairments

Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:

2024
Notes
£
In respect of:
Fixed asset investments
15
15,000
Recognised in:
Amounts written off investments
15,000

The impairment losses in respect of financial assets are recognised in other gains and losses in the profit and loss account.

12
Intangible fixed assets
Group
Goodwill
£
Cost
At 19 September 2024
-
0
Additions
1,189,746
At 31 December 2024
1,189,746
Amortisation and impairment
At 19 September 2024
-
0
Amortisation charged for the period
19,829
At 31 December 2024
19,829
Carrying amount
At 31 December 2024
1,169,917
The company had no intangible fixed assets at 31 December 2024.

More information on impairment movements in the period is given in note 11.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 26 -
13
Tangible fixed assets
Group
Land and buildings
Plant and equipment
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
£
Cost or valuation
At 19 September 2024
-
0
-
0
-
0
-
0
-
0
Additions
112,126
-
0
-
0
-
0
112,126
Business combinations
9,370,822
1,377,371
296,547
12,664
11,057,404
At 31 December 2024
9,482,948
1,377,371
296,547
12,664
11,169,530
Depreciation and impairment
At 19 September 2024
-
0
-
0
-
0
-
0
-
0
Depreciation charged in the period
1,008
1,299
1,557
350
4,214
Additions - business combinations
422,013
1,352,639
267,609
6,049
2,048,310
At 31 December 2024
423,021
1,353,938
269,166
6,399
2,052,524
Carrying amount
At 31 December 2024
9,059,927
23,433
27,381
6,265
9,117,006
The company had no tangible fixed assets at 31 December 2024.

The carrying value of land and buildings comprises:

Group
Company
2024
2024
£
£
Freehold
9,047,746
-
0
Long leasehold
12,181
-
0
9,059,927
-
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
13
Tangible fixed assets
(Continued)
- 27 -

A valuation of both freehold properties took place on 9 September 2024 by qualified professionals working for the company Christie & Co, independent valuers not connected with the company on the basis of market value. The valuation conforms to International Valuation Standards and was valued on a market value based upon its existing use and present condition as a fully-equipped operational entity. The valuation was carried out in accordance with the RICS Valuation standards.

As this valuation was not materially greater than the net book value held in the financial statements, the directors have chosen not to adjust the existing values and revaluation reserve.

 

The Directors consider these valuations to remain current.

The following assets are carried at valuation. If the assets were measured using the cost model, the carrying amounts would be as follows:

2024
£
Group
Cost
6,703,945
14
Investment property
Group
Company
2024
2024
£
£
Fair value
At 19 September 2024 and 31 December 2024
-
-
Additions through external acquisition
265,096
-
Additions through business combinations
3,919,152
-
Disposals
(296,355)
-
At 31 December 2024
3,887,893
-

Investment property comprises of the land transferred from Tangible Assets and further building costs. The fair value of the land has been arrived at on the basis of a valuation carried out at 9 March 2024 by Align Property Partners, independent valuers not connected with the company, on the basis of market value. The valuation conforms to International Valuation Standards and was valued on a market value based upon its present condition. The valuation was carried out in accordance with the RICS Valuation standards.

 

Additional building costs have also been incurred for the development of residential properties intended for future sale.

 

The Directors consider these valuations to remain current.

15
Fixed asset investments
Group
Company
2024
2024
Notes
£
£
Investments in subsidiaries
16
-
0
15,104,163
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
15
Fixed asset investments
(Continued)
- 28 -
Movements in fixed asset investments
Group
Investments
£
Cost or valuation
At 19 September 2024
-
Business combinations
358,100
At 31 December 2024
358,100
Impairment
At 19 September 2024
-
Business combinations
343,100
Impairment losses
15,000
At 31 December 2024
358,100
Carrying amount
At 31 December 2024
-
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 19 September 2024
-
Additions
15,104,163
At 31 December 2024
15,104,163
Carrying amount
At 31 December 2024
15,104,163
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 29 -
16
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Brookfield Care Limited
Victoria House 66-70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ
Ordinary
0
100.00
Czajka Czajka Care Limited
Victoria House 66-70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ
Ordinary
0
100.00
Czajka Properties Limited
Victoria House 66-70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ
Ordinary
0
100.00
Czajka Group Holdings Limited
Victoria House 66-70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ
Ordinary
0
100.00
Fairmount Limited
Victoria House 66-70 Bingley Road, Saltaire, Shipley, West Yorkshire, BD18 4DJ
Ordinary
0
100.00
Redhall Limited
First Floor, Jubilee Building, Victoria Street, Douglas, Isle of Man, IM1 2SH
Ordinary
100.00
-
17
Stocks
Group
Company
2024
2024
£
£
Finished goods and goods for resale
936,174
-
0
18
Debtors
Group
Company
2024
2024
Amounts falling due within one year:
£
£
Trade debtors
383,649
-
0
Other debtors
1,161,823
-
0
Prepayments and accrued income
51,558
-
0
1,597,030
-
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 30 -
19
Creditors: amounts falling due within one year
Group
Company
2024
2024
Notes
£
£
Bank loans and overdrafts
21
3,689,848
-
0
Other borrowings
21
100,000
-
0
Payments received on account
268,515
-
0
Trade creditors
210,674
-
0
Amounts owed to group undertakings
-
0
4,153,274
Corporation tax payable
419,738
-
0
Other taxation and social security
663,749
-
Government grants
23
3,641
-
0
Other creditors
1,786,409
1,416,587
Accruals and deferred income
235,030
-
0
7,377,604
5,569,861

Amounts due to group companies are interest free and repayable on demand.

20
Creditors: amounts falling due after more than one year
Group
Company
2024
2024
Notes
£
£
Debenture loans
21
1,083,869
1,083,869
Bank loans and overdrafts
21
28,516
-
0
Other creditors
1,361,688
1,361,688
2,474,073
2,445,557
Amounts included above which fall due after five years are as follows:
Payable by instalments
1,792,326
1,792,326
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 31 -
21
Loans and overdrafts
Group
Company
2024
2024
£
£
Debenture loans
1,083,869
1,083,869
Bank loans
3,105,608
-
0
Bank overdrafts
612,756
-
0
Other loans
100,000
-
0
4,902,233
1,083,869
Payable within one year
3,789,848
-
0
Payable after one year
1,112,385
1,083,869

Bank loans and overdrafts are secured by a charge held over the freehold land and buildings, together with across guarantee and debenture with Brookfield Care Limited, Czajka Care Limited, Fairmount Limited and Czajka Group Holdings Limited, dated 6 February 2009. A deed of accession was made on 23 October 2024 to add Czajka Care Group Ltd into this charge.

 

Interest on bank overdrafts is charged at standard bank terms.

 

Bank loan 1 - Interest is charged at LIBOR plus 2.00%, expiring in February 2025.

Bank loan 2 - Interest is charged at LIBOR plus 2.75%, expiring in February 2025.

Bank loan 3 - Interest is charged at 20.02%, expiring in December 2026.

 

The debentures loans noted above are secured by a cross guarantee and debenture between Brookfield Care Ltd, Fairmount Ltd, Czajka Properties Limited, Czajka Group Holdings Limited, Czajka Care Group Ltd and Czajka Care Limited, dated 29 October 2024.

 

The debenture loans are payable between 31 December 2036 and 31 December 2058 in equal monthly instalments. No interest is payable on these amounts.

22
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
2024
Group
£
Accelerated capital allowances
95,583
Revaluations
155,992
Retirement benefit obligations
(2,396)
249,179
The company has no deferred tax assets or liabilities.
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
22
Deferred taxation
(Continued)
- 32 -
Group
Company
2024
2024
Movements in the period:
£
£
Asset at 19 September 2024
-
-
Charge to profit or loss
249,179
-
Liability at 31 December 2024
249,179
-

The amount of the net reversal of deferred tax expected to occur next year is £7,000, relating to the reversal of existing timing differences on tangible fixed assets.

23
Government grants
Group
Company
2024
2024
£
£
Arising from government grants
3,641
-
24
Retirement benefit schemes
2024
Defined contribution schemes
£
Charge to profit or loss in respect of defined contribution schemes
17,446

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

 

Included in other creditors, the amount outstanding at the reporting date was £63,923.

25
Share capital
Group and company
2024
2024
Ordinary share capital
Number
£
Issued and fully paid
Ordinary shares of £1 each
2,225
2,225

On incorporation 1 Ordinary £1 share was allotted at par to form the capital base of the company.

 

A further 2,224 Ordinary £1 shares were allotted at a premium on 29 October 2024.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 33 -
26
Acquisition of a business

On 29 October 2024 the group acquired 100 percent of the issued capital of Redhall Limited.

Book Value
Adjustments
Fair Value
Net assets acquired
£
£
£
Property, plant and equipment
9,009,094
-
9,009,094
Investment property
3,919,152
-
3,919,152
Investments
15,000
-
15,000
Inventories
936,174
-
936,174
Trade and other receivables
5,294,440
-
5,294,440
Cash and cash equivalents
250,000
-
250,000
Borrowings
(4,168,685)
-
(4,168,685)
Trade and other payables
(611,308)
-
(611,308)
Tax liabilities
(480,271)
-
(480,271)
Provisions
(249,179)
-
(249,179)
Total identifiable net assets
13,914,417
-
13,914,417
Goodwill
1,189,746
Total consideration
15,104,163
The consideration was satisfied by:
£
Cash
5,521,994
Issue of shares
7,116,659
Issue of debentures
1,072,311
Deferred consideration
1,393,199
15,104,163
27
Financial commitments, guarantees and contingent liabilities

The company has given an unlimited multilateral guarantee in respect of the bank borrowings of other group companies. The amount guaranteed is £3,666,545.

 

Bank loan and overdrafts are secured by a cross guarantee and debenture between Brookfield Care Limited, Fairmount Limited, Czajka Group Holdings Limited, Czajka Properties Limited, Czajka Care Group Ltd and Czajka Care Limited, dated 23 October 2024.

 

The company is a party to a cross guarantee and debenture between Brookfield Care Ltd, Fairmount Ltd, Czajka Properties Limited, Czajka Group Holdings Limited, Czajka Care Group Ltd and Czajka Care Limited, dated 29 October 2024.

This is in relation to deferred consideration payable by Czajka Care Group Ltd.

The amount guaranteed is £3,862,144.

 

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 34 -
28
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2024
£
£
Within one year
186,750
-
Between two and five years
558,229
-
744,979
-
29
Capital commitments

Amounts contracted for but not provided in the financial statements:

Group
Company
2024
2024
£
£
Acquisition of tangible fixed assets
57,925
-
30
Related party transactions
Transactions with related parties

During the period the group entered into the following transactions with related parties:

Purchases
2024
£
Group
Other related parties (common control and common trustees)
33,678

The following amounts were outstanding at the reporting end date:

Amounts due to related parties
2024
£
Group
Other related parties (common control and common trustees)
1,376
31
Directors' transactions

At the balance sheet date the amount due to Konrad Czajka (Director) was £3,862,144.

CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 35 -
32
Controlling party

Ultimate control is not vested in one individual.

33
Cash generated from group operations
2024
£
Profit after taxation
98,004
Adjustments for:
Taxation charged
68,239
Finance costs
81,643
Investment income
(15,822)
Gain on disposal of tangible fixed assets
(54,097)
Amortisation and impairment of intangible assets
19,829
Depreciation and impairment of tangible fixed assets
4,214
Other gains and losses
15,000
Movements in working capital:
Increase in debtors
(159,583)
Increase in creditors
119,597
Increase in deferred income
3,641
Cash generated from operations
180,665
CZAJKA CARE GROUP LTD
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 36 -
34
Analysis of changes in net debt - group
19 September 2024
Cash flows
Acquisitions and disposals
Other non-cash changes
Market value movements
31 December 2024
£
£
£
£
£
£
Cash at bank and in hand
-
357,500
250,000
-
-
607,500
Bank overdrafts
-
(612,756)
-
-
-
(612,756)
-
(255,256)
250,000
-
-
(5,256)
Borrowings excluding overdrafts
-
990,991
(4,168,685)
(1,083,869)
(27,914)
(4,289,477)
-
735,735
(3,918,685)
(1,083,869)
(27,914)
(4,294,733)

The other non cash movement of £1,083,869 is in respect of loan notes issued on acquisition.

2024-12-312024-09-19falsefalseCCH SoftwareCCH Accounts Production 2025.200CzajkaKonrad CzajkaDominic CzajkaDaniel CzajkaJanina Czajkafalse15966077bus:Consolidated2024-09-192024-12-31159660772024-09-192024-12-3115966077bus:Director22024-09-192024-12-3115966077bus:Director32024-09-192024-12-3115966077bus:Director42024-09-192024-12-3115966077bus:CompanySecretary12024-09-192024-12-3115966077bus:Director12024-09-192024-12-3115966077bus:RegisteredOffice2024-09-192024-12-31159660772024-12-3115966077bus:Consolidated2024-12-3115966077core:Goodwillbus:Consolidated2024-12-3115966077core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-12-3115966077core:PlantMachinerybus:Consolidated2024-12-3115966077core:FurnitureFittingsbus:Consolidated2024-12-3115966077core:MotorVehiclesbus:Consolidated2024-12-3115966077core:ShareCapitalbus:Consolidated2024-12-3115966077core:SharePremiumbus:Consolidated2024-12-3115966077core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3115966077core:ShareCapital2024-12-3115966077core:SharePremium2024-12-3115966077core:RetainedEarningsAccumulatedLosses2024-12-3115966077core:ShareCapitalbus:Consolidated2024-09-192024-12-3115966077core:SharePremiumbus:Consolidated2024-09-192024-12-3115966077core:ShareCapital2024-09-192024-12-3115966077core:SharePremium2024-09-192024-12-3115966077core:Goodwill2024-09-192024-12-3115966077core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-192024-12-3115966077core:PlantMachinery2024-09-192024-12-3115966077core:FurnitureFittings2024-09-192024-12-3115966077core:MotorVehicles2024-09-192024-12-3115966077core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-09-192024-12-3115966077core:UKTaxbus:Consolidated2024-09-192024-12-3115966077bus:Consolidated12024-09-192024-12-3115966077bus:Consolidated22024-09-192024-12-3115966077bus:Consolidated32024-09-192024-12-3115966077bus:Consolidated42024-09-192024-12-3115966077bus:Consolidated52024-09-192024-12-3115966077core:Goodwillbus:Consolidated2024-09-1815966077core:Goodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-09-192024-12-3115966077core:Goodwillbus:Consolidated2024-09-192024-12-3115966077core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-09-1815966077core:PlantMachinerybus:Consolidated2024-09-1815966077core:FurnitureFittingsbus:Consolidated2024-09-1815966077core:MotorVehiclesbus:Consolidated2024-09-1815966077bus:Consolidated2024-09-1815966077core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-09-192024-12-3115966077core:PlantMachinerybus:Consolidated2024-09-192024-12-3115966077core:FurnitureFittingsbus:Consolidated2024-09-192024-12-3115966077core:MotorVehiclesbus:Consolidated2024-09-192024-12-3115966077core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3115966077core:LandBuildingscore:LongLeaseholdAssetsbus:Consolidated2024-12-3115966077core:LandBuildingscore:LongLeaseholdAssets2024-12-3115966077core:Subsidiary12024-09-192024-12-3115966077core:Subsidiary22024-09-192024-12-3115966077core:Subsidiary32024-09-192024-12-3115966077core:Subsidiary42024-09-192024-12-3115966077core:Subsidiary52024-09-192024-12-3115966077core:Subsidiary62024-09-192024-12-3115966077core:Subsidiary112024-09-192024-12-3115966077core:Subsidiary222024-09-192024-12-3115966077core:Subsidiary332024-09-192024-12-3115966077core:Subsidiary442024-09-192024-12-3115966077core:Subsidiary552024-09-192024-12-3115966077core:Subsidiary662024-09-192024-12-3115966077core:CurrentFinancialInstruments2024-12-3115966077core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3115966077core:WithinOneYearbus:Consolidated2024-12-3115966077core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3115966077core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3115966077core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3115966077core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3115966077core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3115966077core:Non-currentFinancialInstruments2024-12-3115966077core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated12024-12-3115966077core:Non-currentFinancialInstrumentscore:AfterOneYear22024-12-3115966077bus:PrivateLimitedCompanyLtd2024-09-192024-12-3115966077bus:FRS1022024-09-192024-12-3115966077bus:Audited2024-09-192024-12-3115966077bus:ConsolidatedGroupCompanyAccounts2024-09-192024-12-3115966077bus:FullAccounts2024-09-192024-12-31xbrli:purexbrli:sharesiso4217:GBP